Not to be confused with members of the apolipoprotein A subgroup, including 
APOA1, 
APOA2, 
APOA4 and 
APOA5.
| LPA | 
|---|
|  | 
| | Available structures | 
|---|
 | PDB | Human UniProt search: PDBe RCSB | 
|---|
 | | List of PDB id codes | 
|---|
 | 1I71, 1JFN, 1KIV, 2FEB, 4BV5, 4BV7, 4BVC, 4BVD, 4BVV, 4BVW, 3KIV, 4KIV | 
 | 
 | 
| Identifiers | 
|---|
| Aliases | LPA, AK38, APOA, LP, Lipoprotein(a), Lp(a) | 
|---|
| External IDs | HomoloGene: 87856; GeneCards: LPA; OMA:LPA - orthologs | 
|---|
|  | 
|  | 
|  | 
|  | 
| Wikidata | 
|  | 
Lipoprotein(a) is a low-density lipoprotein variant containing a protein called apolipoprotein(a). Genetic and epidemiological studies have identified lipoprotein(a) as a risk factor for atherosclerosis and related diseases, such as coronary heart disease and stroke.
Lipoprotein(a) was discovered in 1963 by Kåre Berg. The human gene encoding apolipoprotein(a) was successfully cloned in 1987.